The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
Health & family welfare ministry's proposal seeks to restrict sale of antibiotics to check self-medication.
Prodded by patent cliff & increasing competition, it files application for foray into injectible oncology segment.
In an e-mailed interview with Business Standard, Mark Lynas says his opposition to GM was divorced from science.
Says company yet to file audited accounts, without which it can't proceed.
The 12th Plan document describes three average annual growth scenarios - 8%, 6-6.5% and 5-5.5 per cent.
Firms could lose licence if products not launched within 6 months of approval.
From the next financial year, the government will utilise the disinvestment proceeds for recapitalisation of banks and for subscribing to the shares of Central Public Sector Enterprises and preferential allotments.
Some UTs to start from April 1 and other transfers to be launched from January.
Executives caused loss of Rs 11 cr, according to police SIT.
An interview with Ranbaxy CEO and MD Arun Sawhney on the changes in the past four years and how the company plans to address the US concerns.
SFIO official refuses to reveal the nature of additional charges found during investigation.
Sharad Pawar says final draft will go to Cabinet before Tuesday.
Company refuses to comment, says 'matters internal to organisation'
Another cap for imported insulin; domestic manufacturers cry foul.
FinMin had objected and wanted existing cost-plus method retained.
CCI to examine competition part of deals, RBI prudential aspects.
Work to begin after that on corrective measures to meet US regulator's requirements.
Note proposes more checks, transparent data bank in land sale or lease.
The prime minister's scientific advisory council had advocated introduction of GM crops in India, but under strict regulatory mechanism.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances